Welcome to our dedicated page for CENTENE SEC filings (Ticker: CNC), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on CENTENE's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time SEC filing updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into CENTENE's regulatory disclosures and financial reporting.
Centene Corp director Paul J. Diaz reported an equity compensation award of 2,771 restricted stock units, recorded as a grant/award acquisition of common stock at a stated price of $0.0000 per share. According to the award terms, all 2,771 units will vest in full at Centene’s 2027 annual meeting of stockholders, after which the underlying shares become fully earned. Following this transaction, Diaz’s directly reported common stock holdings stand at 2,771 shares.
CENTENE CORP director Paul J. Diaz has filed an initial beneficial ownership report indicating that he holds no company securities. The disclosure lists the security title as "No Securities Beneficially Owned" and reports total beneficial ownership of 0.0000 shares as of 2026-07-28.
Centene Corporation reported strong second-quarter 2026 results, with total revenues of $53,579 million and premium and service revenues of $44,375 million, up 4% from a year earlier. GAAP diluted EPS was $2.19 and adjusted diluted EPS was $2.51, versus diluted losses in the prior-year quarter.
The consolidated health benefits ratio improved to 89.6% from 93.0%, while the SG&A expense ratio edged down to 7.0% and adjusted SG&A to 6.9%. Commercial HBR was 79.2%, Medicare 89.5% and Medicaid 93.9%. Cash flow provided by operations was $3,590 million, and cash, investments and restricted deposits totaled $44,846 million against $16.1 billion of debt, resulting in a debt-to-capitalization ratio of 41.6%.
For 2026, Centene raised total revenue guidance by $6.0 billion to $193.5–$197.5 billion and premium and service revenues to $173.0–$177.0 billion, and updated EPS floors to GAAP diluted EPS greater than $3.11 and adjusted diluted EPS greater than $4.80. The company also announced director Kenneth Burdick’s retirement and appointed Paul Diaz to the Board.
Tyler Lauren M reported acquisition or exercise transactions in this Form 4 filing.
Centene Corporation director Lauren M. Tyler reported an equity compensation grant involving 3,155 shares of restricted stock units on 2026-07-17. According to the filing, these units will vest in full on the date of the company’s 2027 annual meeting of stockholders, bringing Tyler’s direct holdings to 3,216 shares.
Tyler Lauren M reported acquisition or exercise transactions in this Form 4 filing.
Centene Corp director Lauren M. Tyler reported a small stock grant. On the reported date, Tyler received 61 shares of Centene common stock as a grant or award at no purchase price. Following this transaction, Tyler directly holds 61 Centene common shares.
Centene Corp director Kenneth Tanji received an equity grant of 581 shares of Common Stock as a compensation award. The shares were acquired at no cash cost to him, increasing his direct holdings to 12,490 shares. His ownership also includes 3,992 restricted stock units that are subject to vesting requirements.
Centene Corporation director Theodore R. Samuels II received a grant of 465 shares of common stock at no cost as a stock award. After this acquisition, he directly holds 25,212.979 common shares and indirectly holds 32,000 shares through a revocable family trust, which includes 3,992 restricted stock units that vest over time.
Centene Corp director Frederick H. Eppinger received a stock grant. On this date, he acquired 833 shares of Centene common stock at no stated purchase price as a grant or award. Following this award, his directly held position increased to 369,537.658 shares, including 6,654 restricted stock units that are subject to vesting requirements.
Centene director Christopher J. Coughlin reported updated equity holdings, including a new share award. He received a grant of 562 shares of Centene common stock at no cost, classified as a grant or award acquisition and held directly, bringing his direct holdings to 18,710.926 shares.
Coughlin also reports 30,054 shares of common stock held indirectly through a grantor retained annuity trust for the benefit of himself and his adult children, where he serves as sole trustee. Footnotes state his ownership includes 3,992 restricted stock units that are subject to vesting requirements.